Company Filing History:
Years Active: 2011
Title: Innovations in Brain Tissue Damage Therapies by Shin-Zong Lin
Introduction
Shin-Zong Lin is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of medical science, particularly in therapies for brain tissue damage. His innovative work focuses on utilizing cultured pluripotent animal cells to address critical health issues.
Latest Patents
Shin-Zong Lin holds a patent related to brain tissue damage therapies. The patent describes a cultured pluripotent animal cell that is CD13+, CD90+, and CD117−. It also outlines methods for producing this cell and techniques for treating brain tissue damage while increasing the expression level of a neurotrophic factor in a subject. This patent represents a significant advancement in therapeutic approaches for brain injuries.
Career Highlights
Shin-Zong Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to engage in cutting-edge research and contribute to the scientific community. His dedication to innovation in medical therapies has positioned him as a key figure in his field.
Collaborations
Shin-Zong Lin collaborates with esteemed colleagues, including Hung Li and Woei-Cherng Shyu. These partnerships enhance the research efforts and broaden the impact of their findings in the medical field.
Conclusion
Shin-Zong Lin's contributions to brain tissue damage therapies exemplify the importance of innovation in medical science. His work not only advances therapeutic options but also highlights the collaborative spirit of research in academia.